Sector: Pharmaceuticals & Biotechnology

Mid Cap

Caplin Point Labs Share Price

Caplin Point Laboratories Ltd.

₹1,739

46.90(2.77%)

Invest in CAPLIPOINT with up to 2.50x margin.

Trade with MTF

23rd Feb 2026 | 3:28 PM

NSE : CAPLIPOINT

Open Free Demat Account

Caplin Point Labs Performance

Price Movement

₹1739.00

₹1685.70

₹1740.00

↘ Today's Low↗ Today's High

1 Year Performance

₹1739.00

₹1599.00

₹2395.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹1,740.00

Low₹1,685.70

Open at₹1,700.00

Prev Close₹1,692.10

Volumes46.18 K

Avg Price₹1,712.20

Lower Circuit₹1,353.70

Upper Circuit₹2,030.50

Historical Performance

3M High₹1,992.10

3M Low₹1,672.00

1 Yr High₹2,395.00

1 Yr Low₹1,599.00

3 Yr High₹2,641.00

3 Yr Low₹575.00

5 Yr High₹2,641.00

5 Yr Low₹401.00

Caplin Point Labs Fundamentals

Market Cap

High in industry

13,146.20 Cr.

PE Ratio (TTM)

Below industry Median

21.40

Dividend Yield

Below industry Median

0.30

Net Profit TTM

19.1% incr over last year

613.70

Net Profit Growth

19.1% incr over last year

613.70

PEG Ratio

Above industry Median

1.10

ROE

5% decr over last year

19.32

Operating Revenue TTM

2,089.48

Operating Revenue Growth

10.7% incr over last year

Book Value

Above industry Median

4.20

MFI

MFI is mid-range

30.83

RSI

RSI is mid-range

36.57

EPS (TTM)

70.57

Debt to Equity

Face Value

Operating Profit Margin Qtr.

31.81

Operating Profit Qtr.

189.69

Net Profit Qtr.

163.88

Operating Revenue Qtr.

542.77

PB Ratio

4.20

Caplin Point Labs Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	189.22	175.18	182.57	173.61	185.23
Operating Expense	97.50	99.33	95.96	98.57	107.84
Operating Profit	91.72	75.85	86.61	75.04	77.39
Depreciation	6.37	6.02	6.14	6.09	6.01
Interest	0.07	0.05	0.04	0.04	0.04
Tax	29.73	26.41	26.57	23.66	25.46
Net Profit	87.28	102.59	85.89	86.50	74.71

Caplin Point Labs Technicals

Caplin Point Laboratories Ltd. EMA & SMA

₹1739.00

46.90 (2.77%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1710.2

Day EMA10 ₹1730.7

Day EMA12 ₹1737.3

Day EMA20 ₹1757.5

Day EMA26 ₹1770.1

Day EMA50 ₹1814.6

Day EMA100 ₹1883.3

Day EMA200 ₹1935.6

Caplin Point Labs Support and Resistance

Resistance

First Resistance₹1704.97

Second Resistance₹1717.83

Third Resistance₹1729.77

Support

First Support₹1680.17

Second Support₹1668.23

Third Support₹1655.37

Technical Indicators

Day RSI36.57

Day MFI30.83

Day ADX25.33

Day Commodity Channel Index-98.00

William-95.73

Day MACD-32.86

Day MACD Signal Line-25.90

Day ATR52.74

Day ROC125-23.47

Day ROC21-2.53

Caplin Point Labs Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	70.6	70.6	70.6	70.6	70.6	70.6
FII	3.7	4.9	5.7	6.2	6.5	6.6
DII	1.9	2.1	2	2.2	2.1	2
Public	23.9	22.5	21.7	21.1	20.8	20.8

Caplin Point Labs Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	21.45 K	46.12 K	46.50%
Week	30.13 K	57.76 K	52.17%
1 Month	36.01 K	79.2 K	45.46%
6 Month	35.34 K	79.29 K	44.57%

Caplin Point Labs SWOT Analysis

Strengths17

Weakness9

Opportunity3

Threats2

Positive Breakout Second Resistance ( LTP > R2)

Benjamin Graham Value Screen

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Mid-range Performer (DVM)

Rising Net Cash Flow and Cash from Operating activity

PEG lower than Industry PEG

Increasing Revenue every Quarter for the past 8 Quarters

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing Revenue every Quarter for the past 4 Quarters

Increasing profits every quarter for the past 4 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Top Gainers

Caplin Point Labs Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
12 Sep, 2025	3	FINAL	12 Sep, 2025	Equity Share
30 May, 2025	3	INTERIM	30 May, 2025	Equity Share
23 Sep, 2024	2.5	FINAL		Equity Share
31 May, 2024	2.5	INTERIM	31 May, 2024	Equity Share
14 Sep, 2023	2.5	FINAL		Equity Share
09 Jun, 2023	2	INTERIM	09 Jun, 2023	Equity Share
21 Sep, 2022	2	FINAL		Equity Share
23 May, 2022	2	INTERIM	24 May, 2022	Equity Share
20 Sep, 2021	1.5	FINAL		Equity Share
18 May, 2021	1.5	INTERIM	19 May, 2021	Equity Share

Caplin Point Labs Stock Comparison

Financials	Corona Remedies Ltd.	Sudeep Pharma Ltd.	Rubicon Research Ltd.	Sai Life Science Ltd.	OneSource Specialty Pharma Ltd.	Sanofi Consumer Healthcare India Ltd.
Price (₹)	₹1,577	₹628.95	₹780	₹968	₹1,320	₹4,075
% Change	3.47%	-5.40%	-0.01%	2.83%	3.96%	0.75%
Revenue TTM (₹ Cr)	-	-	₹1,598.19	₹2,169.86	₹1,419.33	₹798.10
Net Profit TTM (₹ Cr)	-	-	₹206.20	₹332.94	₹20.10	₹217.90
PE TTM	-	-	62.20	61.50	754.90	43.10
1 Year Return	48.29	6.51	60.63	37.17	3.9	-12.48
ROCE	30.24	34.78	34.76	12.51	3.26	-

Similar Stocks

AKUMS

Akums Drugs & Pharmaceuticals Ltd.

₹ 474.00

-0.91%

BLUEJET

Blue Jet Healthcare Ltd

₹ 391.40

+9.99%

CONCORDBIO

Concord Biotech Ltd.

₹ 1103.00

+0.46%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 687.60

-1.60%

SUPRIYA

Supriya Lifescience Ltd.

₹ 670.00

-1.17%

ACUTAAS

Acutaas Chemicals Ltd.

₹ 2138.50

+1.52%

ALIVUS

Alivus Life Sciences Ltd.

₹ 901.15

-1.08%

COHANCE

Cohance Lifesciences Ltd.

₹ 315.10

+3.18%

ERIS

Eris Lifesciences Ltd.

₹ 1358.00

+1.16%

SYNGENE

Syngene International Ltd.

₹ 448.60

+1.33%

APLLTD

Alembic Pharmaceuticals Ltd.

₹ 774.90

+1.55%

STAR

Strides Pharma Science Ltd.

₹ 872.90

+0.37%

GRANULES

Granules India Ltd.

₹ 598.00

-0.18%

FDC

FDC Ltd.

₹ 383.00

+3.82%

SHILPAMED

Shilpa Medicare Ltd.

₹ 329.00

+1.29%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 900.00

+3.15%

NATCOPHARM

Natco Pharma Ltd.

₹ 886.00

-0.64%

NEULANDLAB

Neuland Laboratories Ltd.

₹ 13507.00

+6.88%

MARKSANS

Marksans Pharma Ltd.

₹ 179.32

+0.53%

SANOFI

Sanofi India Ltd.

₹ 4080.00

+1.34%

PGHL

Procter & Gamble Health Ltd.

₹ 5080.00

+1.21%

JSLL

Jeena Sikho Lifecare Ltd.

₹ 674.90

-2.16%

FAQ's on CAPLIPOINT

What is the current share price of Caplin Point Laboratories Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Caplin Point Laboratories Ltd. is ₹ 1739 on the NSE and ₹ 1730 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Caplin Point Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Caplin Point Laboratories Ltd. is approximately ₹ 13146.2 Cr.

What are the PE and PB ratios for Caplin Point Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Caplin Point Laboratories Ltd. is 21.4, and the Price-to-Book (PB) ratio is 4.2.

What is the 52-Week High and Low for Caplin Point Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Caplin Point Laboratories Ltd. shares was ₹ 2395, and the lowest price was ₹ 1599.

What is the current dividend yield for Caplin Point Laboratories Ltd.?

As of 6 June 2025, the dividend yield for Caplin Point Laboratories Ltd. is 0.3%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Caplin Point Laboratories Ltd.?

Significant shareholdings in Caplin Point Laboratories Ltd. typically include entities such as:

Promoter
Public
FII
Mutual Funds
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Caplin Point Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Caplin Point Laboratories Ltd. is often compared with other major players such as Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies, Sudeep Pharma and Curis Lifesciences for analysis and benchmarking.

What is the latest dividend information for Caplin Point Laboratories Ltd.?

Caplin Point Laboratories Ltd. last declared a FINAL dividend of ₹ 3 per share for the financial period ending 2025. The record date was set as 2025-09-12, and the payment was/is scheduled around 2025-09-12. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy